BRPI0405842A - stabilized pharmaceutical composition of fluorine ether compound for anesthetic use. method for stabilizing a fluorine ether compound. use of stabilizing agent to prevent the degradation of fluorine ether compound - Google Patents

stabilized pharmaceutical composition of fluorine ether compound for anesthetic use. method for stabilizing a fluorine ether compound. use of stabilizing agent to prevent the degradation of fluorine ether compound

Info

Publication number
BRPI0405842A
BRPI0405842A BRPI0405842A BRPI0405842A BR PI0405842 A BRPI0405842 A BR PI0405842A BR PI0405842 A BRPI0405842 A BR PI0405842A BR PI0405842 A BRPI0405842 A BR PI0405842A
Authority
BR
Brazil
Prior art keywords
ether compound
fluorine ether
stabilizing
degradation
pharmaceutical composition
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Ogari De Castro Dr Pacheco
Elisa Mannochio De Souza Russo
Valter Freire Torres Russo
Jose Antonio Martins
Maria Alice Bockelmann
Simone Soares Rosatto
Original Assignee
Cristalia Prod Quimicos Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cristalia Prod Quimicos Farm filed Critical Cristalia Prod Quimicos Farm
Priority to BRPI0405842A priority Critical patent/BRPI0405842B8/en
Priority to JP2006525578A priority patent/JP4253343B2/en
Priority to MXPA06000803A priority patent/MXPA06000803A/en
Priority to PCT/BR2004/000156 priority patent/WO2005023175A2/en
Priority to DE602004007149T priority patent/DE602004007149T2/en
Priority to AT04737744T priority patent/ATE365034T1/en
Priority to US10/566,466 priority patent/US7816409B2/en
Priority to PT04737744T priority patent/PT1663186E/en
Priority to ES04737744T priority patent/ES2289524T3/en
Priority to CN2004800211331A priority patent/CN1997360B/en
Priority to EP04737744A priority patent/EP1663186B1/en
Priority to PL04737744T priority patent/PL1663186T3/en
Publication of BRPI0405842A publication Critical patent/BRPI0405842A/en
Priority to HK07113847.1A priority patent/HK1108633A1/en
Publication of BRPI0405842B1 publication Critical patent/BRPI0405842B1/en
Publication of BRPI0405842B8 publication Critical patent/BRPI0405842B8/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA ESTABILIZADA DE COMPOSTO FLúOR-éTER PARA USO ANESTéSICO. MéTODO PAPA ESTABILIZAR UM COMPOSTO FLúOR-éTER. USO DE AGENTE ESTABILIZANTE PARA IMPEDIR A DEGRADAçãO DE COMPOSTO FLúOR éTER". A presente invenção tem como objetivo a estabilização de um composto flúor-éter contra a degradação proporcionada por substâncias ácidas. Os estabilizantes empregados são selecionados dentre compostos farmacêuticos apropriados e são utilizados no preparo de composições farmacêuticas estabilizadas de um composto flúor-éter. São também descritos método de estabilização de um composto flúor-éter e uso de agentes estabilizantes para impedir a degradação de um composto flúor-éter."STABILIZED PHARMACEUTICAL COMPOSITION OF FLUOR-ETHER COMPOUND FOR ANESTHETIC USE. METHOD FOR STABILIZING A FLUOR-ETHER COMPOSITE. The present invention aims at stabilizing a fluorine ether compound against the degradation provided by acidic substances. The stabilizers employed are selected from the appropriate pharmaceutical compounds and are used in the preparation of stabilized pharmaceutical compositions of a fluorine ether compound. Also described are methods of stabilizing a fluorine ether compound and use of stabilizing agents to prevent degradation of a fluorine ether compound.

BRPI0405842A 2003-09-10 2004-07-29 stabilized pharmaceutical composition of a fluor-ether compound for anesthetic use. method for stabilizing a fluorine-ether compound. use of stabilizing agent to prevent the degradation of fluor ether compound. BRPI0405842B8 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BRPI0405842A BRPI0405842B8 (en) 2004-07-29 2004-07-29 stabilized pharmaceutical composition of a fluor-ether compound for anesthetic use. method for stabilizing a fluorine-ether compound. use of stabilizing agent to prevent the degradation of fluor ether compound.
PT04737744T PT1663186E (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
ES04737744T ES2289524T3 (en) 2003-09-10 2004-08-20 STABLE PHARMACEUTICAL COMPOSITION OF A FLUOROETER COMPOSITE FOR ANESTHETIC USE, PROCEDURE FOR STABILIZING A FLUOROETER COMPOUND, USE OF A STABILIZING AGENT TO AVOID THE DEGRADATION OF A FLUOROETER COMPOUND.
PCT/BR2004/000156 WO2005023175A2 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
DE602004007149T DE602004007149T2 (en) 2003-09-10 2004-08-20 A STABLE PHARMACEUTICAL COMPOSITION OF A FLUORETHER COMPOUND FOR ANESTHESIA, METHOD FOR STABILIZING A FLUORETHER COMPOUND, USE OF A STABILIZER TO EXCLUDE THE DEGRADATION OF A FLUORETHER COMPOUND
AT04737744T ATE365034T1 (en) 2003-09-10 2004-08-20 STABLE PHARMACEUTICAL COMPOSITION OF A FLUORETHER COMPOUND FOR ANESTHESIA, METHOD FOR STABILIZING A FLUORETHER COMPOUND, USE OF A STABILIZING AGENT TO EXCLUDE THE DEGRADATION OF A FLUORETHER COMPOUND
US10/566,466 US7816409B2 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
JP2006525578A JP4253343B2 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of anesthesia fluoroether compound, method for stabilizing fluoroether compound, use of stabilizer to prevent degradation of fluoroether compound
MXPA06000803A MXPA06000803A (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound.
CN2004800211331A CN1997360B (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether com
EP04737744A EP1663186B1 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
PL04737744T PL1663186T3 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
HK07113847.1A HK1108633A1 (en) 2003-09-10 2007-12-19 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0405842A BRPI0405842B8 (en) 2004-07-29 2004-07-29 stabilized pharmaceutical composition of a fluor-ether compound for anesthetic use. method for stabilizing a fluorine-ether compound. use of stabilizing agent to prevent the degradation of fluor ether compound.

Publications (3)

Publication Number Publication Date
BRPI0405842A true BRPI0405842A (en) 2006-03-14
BRPI0405842B1 BRPI0405842B1 (en) 2014-11-11
BRPI0405842B8 BRPI0405842B8 (en) 2021-05-25

Family

ID=36091897

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0405842A BRPI0405842B8 (en) 2003-09-10 2004-07-29 stabilized pharmaceutical composition of a fluor-ether compound for anesthetic use. method for stabilizing a fluorine-ether compound. use of stabilizing agent to prevent the degradation of fluor ether compound.

Country Status (1)

Country Link
BR (1) BRPI0405842B8 (en)

Also Published As

Publication number Publication date
BRPI0405842B8 (en) 2021-05-25
BRPI0405842B1 (en) 2014-11-11

Similar Documents

Publication Publication Date Title
BRPI0508579A (en) compound, pharmaceutical composition, and use of a compound
BR112022024943A2 (en) EFERVESCENT ORAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT
BRPI0415121A (en) particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form
BRPI0615292A8 (en) compositions and methods for preparing poorly soluble water drugs with increased stability
TW200733968A (en) Stabilized lanthanum carbonate compositions
BRPI0606318A2 (en) compound, composition, and use of a compound
MX2009004475A (en) Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same.
PE20100265A1 (en) NEW PHARMACEUTICAL COMPOSITIONS INCLUDING LEVETIRACETAM AND PROCESS FOR ITS PREPARATION
WO2007145991A3 (en) Anti-inflammatory and analgesic compositions and related methods
GEP20125628B (en) Pharmaceutical compositions containing antagonist anti-cd40 antibody
RS51304B (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
ECSP088653A (en) PHARMACEUTICAL FORMULATION FOR AEROSOLS WITH TWO OR MORE ACTIVE PRINCIPLES AND AT LEAST A TENSOACTIVE SUBSTANCE
BRPI0418270A (en) methods of treatment and control, treatment or prevention, control of a central nervous system disorder, and to reduce or prevent an adverse effect, and, pharmaceutical composition
BRPI0509708A (en) pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and / or medium chain triglycerides
WO2006113631A3 (en) Bioenhanced compositions
BRPI0518781A2 (en) pharmaceutical formulation, process for preparing a pharmaceutical formulation, and use of a compound
BRPI0511466B8 (en) peptide vasopressin receptor agonists, pharmaceutical composition comprising said agonists and use thereof
MX2010003923A (en) Pharmaceutical formulation of valsartan.
CY1111369T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3- (3-DIMETHYLAMINE-1-ETHYL-2-Methyl-PROPYL) -PHENOL AND PARAKETAMOL
HK1108633A1 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
BRPI0514250A (en) use of a compound, pharmaceutical composition comprising the same, compounds and method of treatment
BRPI0916282B8 (en) use of a pgi2-receptor agonist in the treatment of chronic renal failure
DK1635792T3 (en) Stable pharmaceutical compositions of 2-aza-bicyclo-3.3.0-octane-3-carboxylic acid derivatives
MX2010006259A (en) Piperazines as anti-obesity agents.
BRPI0409413A (en) pharmaceutical composition, use of an unconjugated bile acid or salt, and methods for enhancing the absorption of an active macromolecular principle in a pacetella and for treating a patient suffering from a treatable condition or disease.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/08, 47/10; C07C 17/42, 19/08; A61P 23/00

Ipc: A61K 31/08 (2011.01), A61K 47/10 (2011.01), C07C 1

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/11/2014, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/07/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF